Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

OriGene Buys Zhongshan Golden Bridge Biotechnology

publication date: Mar 13, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
OriGene Technologies, a research tool maker from the Washington DC area, acquired Beijing Zhongshan Golden Bridge Biotechnology (ZsBio) for an undisclosed sum. Founded in Beijing in 1993, ZsBio provides pathology testing products for China’s oncology diagnostic market. OriGene said the acquisition takes it into the pathology testing market for the first time, while also giving it a leading position in this sector of the Chinese market. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners